Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Smallpox vaccination and bioterrorism with pox viruses.

Anton Mayr1

  • 1Institute of Microbiology, Infectious and Epidemic Diseases of the Veterinary, Faculty of the Ludwig-Maximilian, University of Munich, Weiheimer Strasse 1, 823 19, Starnberg, Germany. a.mayr@pro-starnberg.de

Comparative Immunology, Microbiology and Infectious Diseases
|June 24, 2003
PubMed
Summary

The MVA strain offers a safe and effective alternative to traditional vaccinia virus vaccines for combating pox virus threats. This improved vaccine protects both humans and animals, addressing concerns about historical vaccine complications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same journal

Alphavirus madariaga-associated encephalomyelitis in equines from the Brazilian Pantanal reveals arbovirus circulation in a peri-urban environment.

Comparative immunology, microbiology and infectious diseases·2026
Same journal

Molecular detection, diagnostic evaluation, and genetic characterization of blood-borne pathogens in fighting bulls from southern Thailand.

Comparative immunology, microbiology and infectious diseases·2026
Same journal

A novel lytic bacteriophage BUCT791 effectively controls multidrug-resistant Klebsiella pneumoniae in vitro and in vivo.

Comparative immunology, microbiology and infectious diseases·2026
Same journal

Detection of SARS-CoV-2 and coinfections in companion animals from COVID-19-positive owners in Southeast, Brazil.

Comparative immunology, microbiology and infectious diseases·2026
Same journal

Screening candidate intermediate hosts for porcine respiratory coronavirus using molecular docking.

Comparative immunology, microbiology and infectious diseases·2026
Same journal

Comparison of Igκ and Igλ binding toward influenza virus hemagglutinin and SARS-CoV-2 Spike protein during primary viral infections in humans, mice, and pigs.

Comparative immunology, microbiology and infectious diseases·2026

Area of Science:

  • Virology
  • Public Health
  • Vaccinology

Background:

  • Bioterrorism involving pox viruses, including variola and monkeypox, presents a significant global health risk.
  • Traditional vaccinia virus vaccination, while effective for smallpox eradication, carries risks of severe post-vaccinal complications.
  • Existing smallpox vaccine stocks raise concerns due to potential complications, especially in an increasing population of immune-suppressed individuals.

Purpose of the Study:

  • To evaluate the Modified Vaccinia Virus Ankara (MVA) strain as a safer and equally effective alternative for pox virus vaccination.
  • To address the limitations and risks associated with traditional vaccinia virus vaccines.

Main Methods:

  • Review of historical vaccination data and current vaccine stock challenges.

Related Experiment Videos

  • Assessment of MVA strain's safety and efficacy profile.
  • Evaluation of MVA's applicability in human and animal populations, including parenteral administration.

    • Main Results:

    • The MVA strain is demonstrated to be harmless.
    • MVA provides equivalent protection against smallpox for both humans and animals.
    • Parenteral administration of MVA is feasible.

    Conclusions:

    • The MVA strain represents a viable solution to the dilemma of existing smallpox vaccine stocks.
    • MVA offers a safer vaccination strategy, mitigating the risks of post-vaccinal complications seen with older vaccinia strains.
    • The MVA strain's broad applicability and safety profile make it a crucial tool for future biodefense against pox virus threats.